retatrutide mechanism of action triple agonist glp-1 gip glucagon LY3437943, a novel glucagon, GIP, and receptor for glycemic control and weight loss: From discovery to clinical proof concept Retatrutide vs Tirzepatide: Comprehensive Comparison
Description
It was reported that GLP-1R was expressed in colonic mucosal nerve fibers and showed increased expression in biopsies from individuals with IBS [55] (Fig
Summary The GLP-1 drug market is rapidly expanding, driving strong enthusiasm among companies for GLP-1 drug development
Data Availability No additional data are available
ME-T: Methodology, Visualization, Formal Analysis, Investigation, Writing original draft, Writing review and editing
Obesity Reviews 2021;22:111
and Victoza (liraglutide
